AstraZeneca: Preparing for Rapid Manufacturing Growth With Unified Digital Validation
AstraZeneca, which operates 32 manufacturing sites across 150 countries, faced compliance risk and duplicated effort from paper-based, site-specific validation processes. It implemented Veeva Validation Management integrated with Veeva QMS and QualityDocs to unify digital validation. Following a 2025 go-live at a China site, the page reports a projected 20% reduction in cycle times, and expects quality events -- which had grown from 4,000 in 2022 to over 6,000 in 2025 -- to decrease for the first time in 2026 through more efficient, right-first-time processes.
Veeva Systems is the dominant CRM and content platform in pharma commercial, regulatory, clinical and quality operations, now shipping AI agents directly inside those same production systems.
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Veeva Systems on its own site — read the original case study on veeva.com ↗
Related use cases
- 01Transforming Content Operations for 2x Faster Time to Market
- 02Astellas: Breaking Access Barriers with Veeva Compliant Chat
- 03How Pacira Generated Deep Website Insights to Get Patients on Therapy Faster
- 04Reaching Underserved Communities with Smarter Targeting
- 05Building Agile Territory Strategies to Scale Pre-Commercial Field Teams
- 06How Alfasigma Unified Regulatory Data and Processes for Cross-Functional Alignment